Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationMultiple MyelomaTransplantation ConditioningMelphalanCombined Modality TherapyTreatment OutcomeBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsRemission InductionSalvage TherapyStem CellsHematopoietic Stem Cell MobilizationLymphoma, Non-HodgkinDisease-Free SurvivalRecurrenceHodgkin DiseaseEtoposideLiver TransplantationCarmustineMyeloablative AgonistsCyclophosphamideGraft vs Host DiseaseCytarabineBone Marrow PurgingSurvival RateGraft SurvivalHematologic NeoplasmsVincristineRetrospective StudiesWhole-Body IrradiationSurvival AnalysisHematopoietic Stem CellsThiotepaBusulfanAntigens, CD34Kidney TransplantationFollow-Up StudiesLymphoma, Mantle-CellDexamethasonePrognosisAmyloidosisLeukapheresisCell TransplantationGranulocyte Colony-Stimulating FactorThalidomideAntibodies, Monoclonal, Murine-DerivedBoronic AcidsTime FactorsPyrazinesAntineoplastic Agents, AlkylatingDoxorubicinPrednisoneLymphoma, FollicularAutograftsMesenchymal Stem Cell TransplantationTransplantation ChimeraTissue DonorsLymphoma, T-Cell, PeripheralLymphomaNeoplasm, ResidualHeart TransplantationCord Blood Stem Cell TransplantationIfosfamideImmunosuppressive AgentsLeukemia, Myeloid, AcuteLung TransplantationPodophyllotoxinMyelodysplastic SyndromesAntineoplastic AgentsIdarubicinInduction ChemotherapyBlood Component RemovalLymphoma, Large B-Cell, DiffuseProspective StudiesMaintenance ChemotherapyFeasibility StudiesHistocompatibility TestingGraft RejectionOrgan TransplantationTransplantation ImmunologyEmbryonic Stem CellsBlood Transfusion, AutologousBone MarrowLymphoma, B-CellEnteropathy-Associated T-Cell LymphomaHematopoiesisAntibodies, MonoclonalCell DifferentiationLeukemia, Plasma CellLeukemiaInfusions, SpinalGraft vs Tumor EffectAdult Stem CellsNeoplasms, Second PrimaryHistocompatibilityMitoxantrone